WHO halts hydroxychloroquine and combination of HIV drug trials among hospitalized COVID-19 patients

GENEVA: The World Health Organization on Saturday has halted its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalized COVID-19 patients after they failed to reduce the death rate, Al Jazeera reported.

“These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to the standard of care.